| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |